We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.31%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$111B
AUM Growth
+$1.46B
Cap. Flow
+$2.6B
Cap. Flow %
2.33%
Top 10 Hldgs %
23.97%
Holding
4,345
New
253
Increased
2,150
Reduced
1,535
Closed
239

Sector Composition

Rank Sector Weight
1 Technology 14.75%
2 Financials 9.04%
3 Healthcare 8.25%
4 Consumer Discretionary 6.53%
5 Industrials 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XENT
2601
DELISTED
Intersect ENT, Inc
XENT
$978K ﹤0.01%
+35,951
New +$889K
OCFC icon
2602
OceanFirst Financial
OCFC
$1.9B
$975K ﹤0.01%
45,555
+3,658
+9% +$74.9K
EPR icon
2603
EPR Properties
EPR
$4.74B
$974K ﹤0.01%
19,715
+10,925
+124% +$554K
LSI
2604
DELISTED
Life Storage, Inc.
LSI
$966K ﹤0.01%
8,421
-556
-6% -$66.1K
XSMO icon
2605
Invesco S&P SmallCap Momentum ETF
XSMO
$3.12B
$965K ﹤0.01%
18,126
-7,377
-29% -$391K
STK
2606
Columbia Seligman Premium Technology Growth Fund
STK
$939M
$964K ﹤0.01%
29,252
+394
+1% +$13.3K
TMFS icon
2607
Motley Fool Small-Cap Growth ETF
TMFS
$60.5M
$961K ﹤0.01%
24,551
-1,647
-6% -$65.5K
WBK
2608
DELISTED
Westpac Banking Corporation
WBK
$961K ﹤0.01%
51,858
-4,333
-8% -$80.9K
PROF
2609
Profound Medical
PROF
$241M
$958K ﹤0.01%
65,696
+11,136
+20% +$170K
VVR icon
2610
Invesco Senior Income Trust
VVR
$459M
$956K ﹤0.01%
214,817
-22,197
-9% -$96.5K
BYLD icon
2611
iShares Yield Optimized Bond ETF
BYLD
$442M
$954K ﹤0.01%
37,978
+188
+0.5% +$4.76K
DIN icon
2612
Dine Brands
DIN
$433M
$954K ﹤0.01%
11,747
+809
+7% +$65.1K
DEW icon
2613
WisdomTree Global High Dividend Fund
DEW
$157M
$953K ﹤0.01%
20,360
-1,812
-8% -$87.8K
FDD icon
2614
First Trust STOXX European Select Dividend Income Fund
FDD
$915M
$953K ﹤0.01%
68,550
+4,198
+7% +$61.3K
FHI icon
2615
Federated Hermes
FHI
$4.74B
$953K ﹤0.01%
29,309
-13,427
-31% -$438K
EBS icon
2616
Emergent Biosolutions
EBS
$236M
$951K ﹤0.01%
18,987
+1,331
+8% +$80.6K
RKLB icon
2617
Rocket Lab Corp
RKLB
$50.6B
$949K ﹤0.01%
+58,818
New +$707K
RFV icon
2618
Invesco S&P MidCap 400 Pure Value ETF
RFV
$344M
$947K ﹤0.01%
10,402
+4,592
+79% +$423K
OCUL icon
2619
Ocular Therapeutix
OCUL
$2.14B
$938K ﹤0.01%
93,751
+29,818
+47% +$335K
TXG icon
2620
10x Genomics
TXG
$7.39B
$938K ﹤0.01%
6,440
-2,874
-31% -$493K
ALKT icon
2621
Alkami Technology
ALKT
$2.19B
$936K ﹤0.01%
37,927
+26,700
+238% +$796K
SNBR
2622
DELISTED
Sleep Number
SNBR
$936K ﹤0.01%
10,008
+580
+6% +$57.6K
AMRX icon
2623
Amneal Pharmaceuticals
AMRX
$6.19B
$935K ﹤0.01%
175,052
+2,000
+1% +$10.1K
SPXX icon
2624
Nuveen S&P 500 Dynamic Overwrite Fund
SPXX
$344M
$935K ﹤0.01%
54,725
-9,330
-15% -$168K
ONLN icon
2625
ProShares Online Retail ETF
ONLN
$65M
$933K ﹤0.01%
14,206
-11,231
-44% -$819K

Similar funds

Raymond James & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Raymond James & Associates held 4,345 positions worth $111B, up 1.3% from $110B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2021 filing shows 253 new, 2,150 increased, 1,535 reduced and 239 closed positions. Its largest new stake was GXO Logistics: 224,392 shares worth $17.6M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $358M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2021 buy was GXO Logistics: 224,392 shares worth $17.6M.
  • Raymond James & Associates added most to Vanguard Morningstar Mid-Cap ETF in Q3 2021, an estimated $569M increase.
  • Raymond James & Associates's biggest Q3 2021 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $358M.
  • Raymond James & Associates fully exited Invesco S&P 500 Equal Weight Energy ETF in Q3 2021, selling an estimated $9.16M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $111B portfolio in Q3 2021.
  • Raymond James & Associates opened 253 new positions and closed 239 in Q3 2021.
  • Raymond James & Associates's portfolio value rose 1.3% quarter-over-quarter to $111B.

Based on Raymond James & Associates's 13F filing for Q3 2021, filed 2 Nov 2021.